Plain-English translation of NCT07768189 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new cancer medicine called to see if it can help people with advanced oropharyngeal cancer (cancer of the throat, tonsils, or base of tongue) that has come back or spread after previous treatment. is a targeted therapy that delivers chemotherapy directly to cancer cells. The study will compare how well this medication works compared to standard cancer drugs that doctors typically use for this type of cancer.
People whose throat cancer returns or spreads after chemotherapy and immunotherapy have very few treatment options, and current standard treatments don't work well enough for many patients. This trial is testing whether this new targeted medication can help patients live longer and control their cancer better.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic every three weeks to receive either the new medication or a standard cancer drug by intravenous infusion (through an IV). You will continue treatment until your cancer stops responding or cannot be measured on scans. Every six weeks, you will have CT or MRI scans to see how the treatment is working, and you will complete questionnaires about your health and quality of life. Your doctor will monitor you closely for any side effects throughout the study.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States